Implantable cardioverter defibrillator therapy for patients with life-threatening ventricular arrhythmias and severe heart failure

被引：0

作者：

Mecca, A ^{[1
]}

Barakat, T ^{[1
]}

Guo, HS ^{[1
]}

Olshansky, B ^{[1
]}

机构：

[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2000年 / 86卷 / 08期

关键词：

D O I：

10.1016/S0002-9149(00)01110-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Of 533 patients with implantable cardioverter defibrillator (ICD) implants, 40 who had malignant ventricular arrhythmias and functional class IV heart failure (mean age 65 +/- 7 years, mean left ventricular ejection fraction 0.24 +/- 0.08) were found to have a mean time to the first appropriate ICD therapy to death of 25 +/- 22 months and a mean actuarial survival of 64 +/- 5 months. Prolonged survival can occur, and appropriate therapy can be delivered, by an ICD in high-risk patients with functional class IV heart failure who have malignant ventricular arrhythmias.

引用

页码：875 / +

页数：5